Consistent with Treg transfusion before testosterone propionate injection, transfer of CD39− Tregs did not improve BPH (Figure 6C), and Foxp3+ cells were rarely observed around inflammatory cells in the prostate (Figure 6D). Here, FOXP3 is linked to benign prostatic hyperplasia.